Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ciro Romano, Aldo Marrone, Raffaele Galiero, Pia Clara Pafundi, Carlo Acierno, Erica Vetrano & Luigi Elio Adinolfi. (2021) Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals. Expert Review of Gastroenterology & Hepatology 15:6, pages 643-656.
Read now
Read now
Mohammad Haykal, Akira Matsumori, Ahmed Saleh, Moatez Fayez, Hany Negm, Mohammad Shalaby & Samar Bassuony. (2021) Diagnosis and treatment of HCV heart diseases. Expert Review of Cardiovascular Therapy 19:6, pages 493-499.
Read now
Read now
Luigi Elio Adinolfi, Luca Rinaldi, Aldo Marrone & Mauro Giordano. (2018) The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C. Expert Review of Anti-infective Therapy 16:8, pages 595-597.
Read now
Read now
Luigi E Adinolfi, Luciano Restivo & Aldo Marrone. (2013) The predictive value of steatosis in hepatitis C virus infection. Expert Review of Gastroenterology & Hepatology 7:3, pages 205-213.
Read now
Read now
M.A. Ibrahim, D. Sany, Y. El Shahawy & A. Awdallah. (2012) Effect of Activated Vitamin D on Glucoparameters in HCV Seropositive and Seronegative Patients on Chronic Hemodialysis. Renal Failure 34:10, pages 1188-1194.
Read now
Read now
Luigi E Adinolfi, Luciano Restivo, Rosa Zampino, Amedeo Lonardo & Paola Loria. (2011) Metabolic alterations and chronic hepatitis C: treatment strategies. Expert Opinion on Pharmacotherapy 12:14, pages 2215-2234.
Read now
Read now
Geoffrey M Dusheiko & Michael Graham Jacobs. (2009) Perspectives on the management of chronic hepatitis B and C. Expert Review of Anti-infective Therapy 7:3, pages 243-247.
Read now
Read now
Articles from other publishers (49)
Muneerah Hamad Aldubaie, Prarthana M. Suryavamshi, Uma M. Irfan, Hamad A. Al-Hamed, Turki Abdullah Almogbel, Ahmad Almatroudi, Faris Alrumaihi & Khaled Allemailem. (2023) Prevalence of Hepatitis C Viral Infection among Diabetes Mellitus Patients in Qassim Region, Saudi Arabia. Journal of Pure and Applied Microbiology.
Crossref
Crossref
So Hee Park, Jiyun Park, So Yoon Kwon, You-Bin Lee, Gyuri Kim, Kyu Yeon Hur, Janghyun Koh, Jae Hwan Jee, Jae Hyeon Kim, Mira Kang & Sang-Man Jin. (2023) Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD. Scientific Reports 13:1.
Crossref
Crossref
Ahmad Nawaz, Javeria Kiran, Amina Zafar, Shahroz Alam, Muhammad Amjad Bashir, Munaza Batool, Sagheer Atta, Mamoona Noreen, Muhammad Yousaf Ali, Khizar Samiullah, Riffat Yasin, Mahroz Fazal, Wadi B. Alonazi, Awais Amjad, Safdar Hussain, Umair Khurshid & Muhammad Essa. (2023) A study on causes and community response regarding diabetes as a community disease of southern Punjab Pakistan. Journal of King Saud University - Science 35:3, pages 102519.
Crossref
Crossref
Marian-Sorin Popescu, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Radu Mitruț, Andreea Letitia Arsene, Dragoș Nicolae Mărgăritescu, Daniela Calina, Anca Oana Docea & Paul Mitruț. (2022) Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection. Biomedicines 10:9, pages 2093.
Crossref
Crossref
Bahawal Sana, Abdul Manan, Huma Khan, Muhammad Amjad Bashir, Muhammad Shahid Nisar, Khizer Samiullah, Irum Aziz, Muhammad Farooq, Asma Noreen, Talat Bilal Yasoob, Afrah Fahad Alkhuriji, Nawal M. Al-Malahi, Abdulrahman Alasmari, Mohammed Ali Alshehri, Munaza Batool, Awais Amjad & Sagheer Atta. (2022) A demographic study on causes of hepatitis transitions among the agricultural community. Journal of King Saud University - Science 34:5, pages 102085.
Crossref
Crossref
Anca Trifan, Ermina Stratina, Adrian Rotaru, Remus Stafie, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Catalin Sfarti, Camelia Cojocariu, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap & Carol Stanciu. (2022) Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response. Diagnostics 12:3, pages 702.
Crossref
Crossref
Imad M El-Kebbi, Nayda H Bidikian, Layal Hneiny & Mona Philippe Nasrallah. (2021) Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action. World Journal of Diabetes 12:9, pages 1401-1425.
Crossref
Crossref
Yujin Ding, Guangdi Li, Zhiguang Zhou & Tuo Deng. (2021) Molecular mechanisms underlying hepatitis C virus infection-related diabetes. Metabolism 121, pages 154802.
Crossref
Crossref
Amedeo Lonardo & Alessandro Mantovani. (2021) Clearing hepatitis C virus with direct antiviral agents reduces cardiovascular events in patients with prediabetes. Commentary to Sasso and colleagues. Nutrition, Metabolism and Cardiovascular Diseases 31:8, pages 2354-2357.
Crossref
Crossref
Luigi E. Adinolfi, Salvatore Petta, Anna L. Fracanzani, Riccardo Nevola, Carmine Coppola, Vincenzo Narciso, Luca Rinaldi, Vincenza Calvaruso, Pia Clara Pafundi, Rosa Lombardi, Laura Staiano, Vito Di Marco, Antonio Solano, Aldo Marrone, Mariarosaria Saturnino, Francesca Rini, Barbara Guerrera, Graziano Troina, Mauro Giordano, Antonio Craxì & Ferdinando C. Sasso. (2020) Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: A prospective study. Diabetes, Obesity and Metabolism 22:12, pages 2408-2416.
Crossref
Crossref
Yue Gong & Wei Cun. (2019) The Role of ApoE in HCV Infection and Comorbidity. International Journal of Molecular Sciences 20:8, pages 2037.
Crossref
Crossref
Yi-Hao Yen, Fang-Ying Kuo, Kwong-Ming Kee, Kuo-Chin Chang, Ming-Chao Tsai, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung & Chien-Hung Chen. (2019) Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients. Digestive and Liver Disease 51:1, pages 142-148.
Crossref
Crossref
Fatemeh Farshadpour, Reza Taherkhani, Mohammad Reza Ravanbod & Seyed Sajjad Eghbali. (2018) Prevalence and Genotype Distribution of Hepatitis C Virus Infection among Patients with Type 2 Diabetes Mellitus. Medical Principles and Practice 27:4, pages 308-316.
Crossref
Crossref
Stuart C. Gordon & Humberto C. Gonzalez. 2017. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
218
243
.
Prashant Pandya, Chaitanya Pant, Ryan Taylor & Olurinde Oni. (2023) Impact of Sustained Virological Response to Chronic Hepatitic C Antiviral Therapy on New Onset Diabetes Mellitus Type 2 after Controlling for Metabolic Syndrome. Journal of Investigative Medicine 65:4, pages 765-771.
Crossref
Crossref
Дьякович, Olga Dyakovich, Кузнецова & Yuliya Kuznetsova. (2016) characteristics of liver enzyme in various pathologies of the pancreas. Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук 1:5, pages 19-21.
Crossref
Crossref
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher & Amedeo Lonardo. (2016) Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight. International Journal of Molecular Sciences 17:3, pages 355.
Crossref
Crossref
Ester Vanni, Elisabetta Bugianesi & Giorgio Saracco. (2016) Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?. Digestive and Liver Disease 48:2, pages 105-111.
Crossref
Crossref
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona & Giovanni Targher. (2016) Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World Journal of Gastroenterology 22:44, pages 9674.
Crossref
Crossref
Sheng-Han Wang, Shiou-Hwei Yeh & Pei-Jer Chen. 2016. Hepatitis C Virus II. Hepatitis C Virus II
109
136
.
Amr Shaaban Hanafy, Alaa Ahmad Farag, Hassan Mahmoud Hassanin & Ahmad Mahmoud Hassaneen. (2016) Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti-HCV combination therapy. Journal of Medical Virology 88:1, pages 86-93.
Crossref
Crossref
Sara Salehi Hammerstad, Shira Frankel Grock, Hanna J. Lee, Alia Hasham, Nina Sundaram & Yaron Tomer. (2015) Diabetes and Hepatitis C: A Two-Way Association. Frontiers in Endocrinology 6.
Crossref
Crossref
Huseyin Korkmaz, Recep Kesli, Barıs Onder Pamuk, Suleyman Hilmi Ipekci, Yuksel TerziLevent Kebapcilar. (2023) Assessment of Evidence for Positive Association and Seroprevalence of Hepatitis B and C in Diabetic Patients in a Developing Country. Journal of Investigative Medicine 63:2, pages 251-257.
Crossref
Crossref
Luigi Elio Adinolfi. (2015) Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview. World Journal of Gastroenterology 21:8, pages 2269.
Crossref
Crossref
P. Loria, G. Marchesini, F. Nascimbeni, S. Ballestri, M. Maurantonio, F. Carubbi, V. Ratziu & A. Lonardo. (2014) Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Atherosclerosis 232:1, pages 99-109.
Crossref
Crossref
Xuan Guo, Min Jin, Ming Yang, Ke Liu & Jun-wen Li. (2013) Type 2 Diabetes Mellitus and the Risk of Hepatitis C Virus Infection: A systematic review. Scientific Reports 3:1.
Crossref
Crossref
Fabio Nascimbeni, Raluca Pais, Stefano Bellentani, Christopher Paul Day, Vlad Ratziu, Paola Loria & Amedeo Lonardo. (2013) From NAFLD in clinical practice to answers from guidelines. Journal of Hepatology 59:4, pages 859-871.
Crossref
Crossref
Masao Omata & Tatsuo KandaLuigi E AdinolfiRosa ZampinoLuciano RestivoAmedeo LonardoPaola Loria. 2013. Emerging Therapeutic Options for Hepatitis C. Emerging Therapeutic Options for Hepatitis C
86
97
.
Christos V. Rizos & Moses S. Elisaf. (2013) Metformin and cancer. European Journal of Pharmacology 705:1-3, pages 96-108.
Crossref
Crossref
S. Petta, A. Handberg, G. Marchesini, C. Cammà, V. Di Marco, D. Cabibi, F. S. Macaluso & A. Craxì. (2012) High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C. Journal of Viral Hepatitis 20:3, pages 174-182.
Crossref
Crossref
Salvatore Petta, Chiara Rosso, Reynold Leung, Maria Lorena Abate, David Booth, Federico Salomone, Roberto Gambino, Mario Rizzetto, Paolo Caviglia, Antonina Smedile, Stefania Grimaudo, Calogero Cammà, Antonio Craxì, Jacob George & Elisabetta Bugianesi. (2013) Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Virologic Response in Patients With Genotype 1 Chronic Hepatitis C. Clinical Gastroenterology and Hepatology 11:3, pages 311-317.e1.
Crossref
Crossref
Rosa Zampino, Aldo Marrone, Luciano Restivo, Barbara Guerrera, Ausilia Sellitto, Luca Rinaldi, Ciro Romano & Luigi E Adinolfi. (2013) Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World Journal of Hepatology 5:10, pages 528.
Crossref
Crossref
Yoshinao Kobayashi, Motoh Iwasa, Hirohide Miyachi, Ryosuke Sugimoto, Hideaki Tanaka, Rumi Mifuji-Moroka, Naoki Fujita, Yasuhiro Sumida & Yoshiyuki Takei. (2013) Effect of Iron-Mediated Oxidative Stress on Insulin Resistance Through the Forkhead Box-Containing Protein O Subfamily-1 (FOXO-1) Pathway in Chronic Hepatitis C. International Journal of Clinical Medicine 04:01, pages 10-18.
Crossref
Crossref
Muhammad Sadik Memon, Zain Islam Arain, Farukh Naz, Madiha Zaki, Suresh Kumar & Asif Ali Burney. (2013) Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian Study. Journal of Diabetes Research 2013, pages 1-7.
Crossref
Crossref
Lauren M. Kucirka, Thomas G. Peters & Dorry L. Segev. (2012) Impact of Donor Hepatitis C Virus Infection Status on Death and Need for Liver Transplant in Hepatitis C Virus–Positive Kidney Transplant Recipients. American Journal of Kidney Diseases 60:1, pages 112-120.
Crossref
Crossref
Salvatore Petta. (2012) Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: Spectators or actors?. Digestive and Liver Disease 44:5, pages 359-360.
Crossref
Crossref
Salvatore Petta, Daniele Torres, Giovanni Fazio, Calogero Cammà, Daniela Cabibi, Vito Di Marco, Anna Licata, Giulio Marchesini, Alessandra Mazzola, Gaspare Parrinello, Salvatore Novo, Giuseppe Licata & Antonio Craxì. (2012) Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. Hepatology 55:5, pages 1317-1323.
Crossref
Crossref
Camila Ripoll Kappel, Nélson A. Kretzmann & Mário Reis Álvares-da-Silva. (2012) IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative Study. International Journal of Hepatology 2012, pages 1-6.
Crossref
Crossref
Matheus Truccolo Michalczuk, Camila Rippol Kappel, Oscar Birkhan, Ana Carolina Bragança & Mário Reis Álvares-da-Silva. (2012) HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients. International Journal of Hepatology 2012, pages 1-7.
Crossref
Crossref
Giovanni Guaraldi, Amedeo Lonardo, Stefano Ballestri, Stefano Zona, Chiara Stentarelli, Gabriella Orlando, Federica Carli, Lucia Carulli, Alberto Roverato & Paola Loria. (2011) Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. Archives of Medical Research 42:8, pages 690-697.
Crossref
Crossref
S. Petta, V. Di Marco, R. Di Stefano, D. Cabibi, C. Cammà, G. Marchesini & A. Craxì. (2011) TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. Journal of Viral Hepatitis 18:7.
Crossref
Crossref
Salvatore Petta, Claudio Tripodo, Stefania Grimaudo, Daniela Cabibi, Calogero Cammà, Antonietta Di Cristina, Vito Di Marco, Gaetano Di Vita, Sabrina Ingrao, Alessandra Mazzola, Giulio Marchesini, Rosaria Pipitone & Antonio Craxì. (2011) High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis. Digestive and Liver Disease 43:5, pages 404-410.
Crossref
Crossref
Anurag Maheshwari & Paul J. Thuluvath. (2011) Endocrine Diseases and the Liver. Clinics in Liver Disease 15:1, pages 55-67.
Crossref
Crossref
Arun J. Sanyal, Seung Kew Yoon & Riccardo Lencioni. (2010) The Etiology of Hepatocellular Carcinoma and Consequences for Treatment. The Oncologist 15:S4, pages 14-22.
Crossref
Crossref
Salvatore Petta, Marco Amato, Daniela Cabibi, Calogero Cammà, Vito Di Marco, Carla Giordano, Aldo Galluzzo & Antonio Craxì. (2010) Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology 52:5, pages 1543-1552.
Crossref
Crossref
Barbara C. Böckle & Norbert T. Sepp. (2010) Hepatitis C virus and autoimmunity. Autoimmunity Highlights 1:1, pages 23-35.
Crossref
Crossref
E. Matteucci, M. Ghimenti, C. Consani, S. Di Beo & O. Giampietro. (2010)
About CD26
high
CD8
+
Lymphocytes in Type 1 Diabetes Mellitus
. Scandinavian Journal of Immunology 71:2, pages 123-124.
Crossref
Crossref
Amedeo LonardoPaola Loria. (2010) Article Commentary: Insulin Resistance, Type 2 Diabetes and Chronic Liver Disease. A Deadly Trio. Clinical medicine. Endocrinology and diabetes 2, pages CMED.S3518.
Crossref
Crossref
Valter Donadon, Massimiliano Balbi, Antonio Perciaccante, Pietro Casarin & Giorgio Zanette. (2009) Insulin Resistance and Hyperinsulinemia in Patients with Chronic Liver Disease and Hepatocellular Carcinoma. Clinical medicine. Endocrinology and diabetes 2, pages CMED.S3116.
Crossref
Crossref